The expression of the aforementioned tumor suppressive miRNAs has been closely related to farnesoid X receptor (FXR) overexpression, which constitutes a BA receptor, implying gender disparity in HCC risk [183,184]. This evidence concerns the gene NR1H4 and neoplasm.